Healthcare

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE), a biotechnology company focused on developing disease-modifying treatments for neurodegenerative diseases, has announced the completion of clinical evaluations for the last patient in its ATH434-202 Phase 2 trial. This open-label study is designed to assess the safety, efficacy, …

Telix Pharmaceuticals Ltd (ASX:TLX) continues its upward trajectory, with shares climbing 1.5% in Friday morning trade to AU$28.22. This marks an impressive 112.6% gain over the past year, significantly boosting investor returns.

Compumedics Limited (ASX:CMP) has confirmed a new MEG system contract with Hangzhou Normal University (HZNU) in China, reinforcing its position as the leading supplier of MEG technology in the country.

Shares of Australian infection prevention company Nanosonics Ltd (ASX:NAN) soared 13% on Thursday, reaching a 52-week high of AU$4.95. The surge comes after the company announced a major milestone: U.S. Food and Drug Administration (FDA) De Novo clearance for its CORIS system, a groundbreaking …

Shares of Imugene Ltd (ASX:IMU) soared on Wednesday, gaining 11% to 3.9 cents after the clinical-stage immuno-oncology company secured a major regulatory milestone in the United States. The rally comes despite broader market weakness, with the All Ordinaries Index falling 0.4% in early trade.